Some of this work has examined effects on the dopamine-glutamate axis in rat models of amphetamine-induced behavioral sensitization
For example, the Wegovy (semaglutide) prescribing information and Zepbound (tirzepatide) prescribing information describe stepwise start low and go slow titration to a maintenance dose that was tested in clinical trials and approved by regulators.[3,4] A microdose schedule is different and always off-label
Each myth is addressed with actual clinical trial data, mechanism explanations, and context that social media strips away
Tirzepatide, the active ingredient in Mounjaro and Zepbound, is a 39-amino acid dual agonist targeting both GLP-1 and GIP receptors, also incorporating a fatty acid modification for half-life extension, and is the most commercially significant synthetic peptide ever produced at scale
It does not need to be complicated